February 16, 2016
Asahi Kasei Pharma and Pfizer said on February 15 that they will put an end to their copromotion arrangement in Japan for the anticoagulant Recomodulin (recombinant thrombomodulin alfa), which has been in place since November 2013. Their copromotion deal will...read more